Liferay Portal/DXP up to 7.4.3.132 Authenticated User Via Endpoint endpoint cross-site request forgery
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.4 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic has been found in Liferay Portal and DXP up to 7.4.3.132. Impacted is an unknown function of the component Authenticated User Via Endpoint. Performing a manipulation of the argument endpoint results in cross-site request forgery. This vulnerability is known as CVE-2025-43745. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability, which was classified as problematic, was found in Liferay Portal and DXP up to 7.4.3.132. This affects some unknown processing of the component Authenticated User Via Endpoint. The manipulation of the argument endpoint with an unknown input leads to a cross-site request forgery vulnerability. CWE is classifying the issue as CWE-352. The web application does not, or can not, sufficiently verify whether a well-formed, valid, consistent request was intentionally provided by the user who submitted the request. This is going to have an impact on integrity. The summary by CVE is:
A CSRF vulnerability in Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q2.0 through 2025.Q2.7, 2025.Q1.0 through 2025.Q1.14, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.19 and 7.4 GA through update 92 allows remote attackers to performs cross-origin request on behalf of the authenticated user via the endpoint parameter.
It is possible to read the advisory at liferay.dev. This vulnerability is uniquely identified as CVE-2025-43745 since 04/17/2025. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.4
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.5
NVD Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross-site request forgeryCWE: CWE-352 / CWE-862 / CWE-863
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
04/17/2025 CVE reserved08/19/2025 Advisory disclosed
08/19/2025 VulDB entry created
12/15/2025 VulDB entry last update
Sources
Advisory: liferay.devStatus: Confirmed
CVE: CVE-2025-43745 (🔒)
GCVE (CVE): GCVE-0-2025-43745
GCVE (VulDB): GCVE-100-320655
Entry
Created: 08/19/2025 23:26Updated: 12/15/2025 22:07
Changes: 08/19/2025 23:26 (67), 12/15/2025 22:07 (12)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.